{"id":30184,"date":"2020-10-20T12:00:00","date_gmt":"2020-10-20T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/"},"modified":"2020-10-20T12:00:00","modified_gmt":"2020-10-20T12:00:00","slug":"dernier-essai-recovery-sur-la-covid-19","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/dernier-essai-recovery-sur-la-covid-19\/","title":{"rendered":"Dernier essai RECOVERY sur la COVID-19"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1214 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Pr\u00e8s de 40 millions de personnes ont d\u00e9sormais \u00e9t\u00e9 diagnostiqu\u00e9es avec la COVID-19, entra\u00eenant plus d\u2019un million de d\u00e9c\u00e8s dans le monde. La recherche d\u2019un vaccin se poursuit toutefois \u00e0 un rythme soutenu, mais tant que cela reste un v\u0153u pieux, les traitements se sont consid\u00e9rablement am\u00e9lior\u00e9s, tout comme les r\u00e9sultats pour les patients. \u00c0 l\u2019Universit\u00e9 d\u2019Oxford, au Royaume-Uni, le plus grand essai mondial de th\u00e9rapies potentielles (appel\u00e9 essai RECOVERY) est en cours, dont l\u2019acronyme signifie \u00ab Randomised Evaluation of COVID-19 Therapy \u00bb (\u00e9valuation randomis\u00e9e de la th\u00e9rapie contre la COVID-19).  <\/p>\n<p>Le professeur Richard Haynes, professeur de m\u00e9decine et coordinateur de l\u2019essai RECOVERY \u00e0 l\u2019Universit\u00e9 d\u2019Oxford, explique que plus de 14\u202f000 patients ont \u00e9t\u00e9 recrut\u00e9s pour cet essai sp\u00e9cifique dans de nombreux h\u00f4pitaux. Les patients atteints de la COVID-19, confirm\u00e9e ou suspect\u00e9e, et admis \u00e0 l\u2019h\u00f4pital \u00e9taient \u00e9ligibles \u00e0 cet essai. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1215 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/irc8PzsB2q0?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pr\u00e8s de 40 millions de personnes ont d\u00e9sormais \u00e9t\u00e9 diagnostiqu\u00e9es avec la COVID-19, entra\u00eenant plus d\u2019un million de d\u00e9c\u00e8s dans le monde. La recherche d\u2019un vaccin se poursuit toutefois \u00e0 un rythme soutenu, mais tant que cela reste un v\u0153u pieux, les traitements se sont consid\u00e9rablement am\u00e9lior\u00e9s, tout comme les r\u00e9sultats pour les patients. \u00c0 l\u2019Universit\u00e9 d\u2019Oxford, au Royaume-Uni, le plus grand essai mondial de th\u00e9rapies potentielles (appel\u00e9 essai RECOVERY) est en cours, dont l\u2019acronyme signifie \u00ab Randomised Evaluation of COVID-19 Therapy \u00bb (\u00e9valuation randomis\u00e9e de la th\u00e9rapie contre la COVID-19). Le professeur Richard Haynes, professeur de m\u00e9decine et coordinateur de l\u2019essai RECOVERY \u00e0 l\u2019Universit\u00e9 d\u2019Oxford, explique que plus de 14\u202f000 patients ont \u00e9t\u00e9 recrut\u00e9s pour cet essai sp\u00e9cifique dans de nombreux h\u00f4pitaux. Les patients atteints de la COVID-19, confirm\u00e9e ou suspect\u00e9e, et admis \u00e0 l\u2019h\u00f4pital \u00e9taient \u00e9ligibles \u00e0 cet essai.<\/p>\n","protected":false},"author":1,"featured_media":30203,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[170,171,301],"class_list":["post-30184","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-professionnels-de-sante","tag-actualites-euforea","tag-covid-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Dernier essai RECOVERY sur la COVID-19 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dernier essai RECOVERY sur la COVID-19\" \/>\n<meta property=\"og:description\" content=\"Pr\u00e8s de 40 millions de personnes ont d\u00e9sormais \u00e9t\u00e9 diagnostiqu\u00e9es avec la COVID-19, entra\u00eenant plus d\u2019un million de d\u00e9c\u00e8s dans le monde. La recherche d\u2019un vaccin se poursuit toutefois \u00e0 un rythme soutenu, mais tant que cela reste un v\u0153u pieux, les traitements se sont consid\u00e9rablement am\u00e9lior\u00e9s, tout comme les r\u00e9sultats pour les patients. \u00c0 l\u2019Universit\u00e9 d\u2019Oxford, au Royaume-Uni, le plus grand essai mondial de th\u00e9rapies potentielles (appel\u00e9 essai RECOVERY) est en cours, dont l\u2019acronyme signifie \u00ab Randomised Evaluation of COVID-19 Therapy \u00bb (\u00e9valuation randomis\u00e9e de la th\u00e9rapie contre la COVID-19). Le professeur Richard Haynes, professeur de m\u00e9decine et coordinateur de l\u2019essai RECOVERY \u00e0 l\u2019Universit\u00e9 d\u2019Oxford, explique que plus de 14\u202f000 patients ont \u00e9t\u00e9 recrut\u00e9s pour cet essai sp\u00e9cifique dans de nombreux h\u00f4pitaux. Les patients atteints de la COVID-19, confirm\u00e9e ou suspect\u00e9e, et admis \u00e0 l\u2019h\u00f4pital \u00e9taient \u00e9ligibles \u00e0 cet essai.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/\",\"name\":\"Dernier essai RECOVERY sur la COVID-19 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Latest20Recovery20Trial20on20COVID-1920.png\",\"datePublished\":\"2020-10-20T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Latest20Recovery20Trial20on20COVID-1920.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Latest20Recovery20Trial20on20COVID-1920.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/dernier-essai-recovery-sur-la-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Dernier essai RECOVERY sur la COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Dernier essai RECOVERY sur la COVID-19 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/","og_locale":"fr_FR","og_type":"article","og_title":"Dernier essai RECOVERY sur la COVID-19","og_description":"Pr\u00e8s de 40 millions de personnes ont d\u00e9sormais \u00e9t\u00e9 diagnostiqu\u00e9es avec la COVID-19, entra\u00eenant plus d\u2019un million de d\u00e9c\u00e8s dans le monde. La recherche d\u2019un vaccin se poursuit toutefois \u00e0 un rythme soutenu, mais tant que cela reste un v\u0153u pieux, les traitements se sont consid\u00e9rablement am\u00e9lior\u00e9s, tout comme les r\u00e9sultats pour les patients. \u00c0 l\u2019Universit\u00e9 d\u2019Oxford, au Royaume-Uni, le plus grand essai mondial de th\u00e9rapies potentielles (appel\u00e9 essai RECOVERY) est en cours, dont l\u2019acronyme signifie \u00ab Randomised Evaluation of COVID-19 Therapy \u00bb (\u00e9valuation randomis\u00e9e de la th\u00e9rapie contre la COVID-19). Le professeur Richard Haynes, professeur de m\u00e9decine et coordinateur de l\u2019essai RECOVERY \u00e0 l\u2019Universit\u00e9 d\u2019Oxford, explique que plus de 14\u202f000 patients ont \u00e9t\u00e9 recrut\u00e9s pour cet essai sp\u00e9cifique dans de nombreux h\u00f4pitaux. Les patients atteints de la COVID-19, confirm\u00e9e ou suspect\u00e9e, et admis \u00e0 l\u2019h\u00f4pital \u00e9taient \u00e9ligibles \u00e0 cet essai.","og_url":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/","url":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/","name":"Dernier essai RECOVERY sur la COVID-19 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Latest20Recovery20Trial20on20COVID-1920.png","datePublished":"2020-10-20T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Latest20Recovery20Trial20on20COVID-1920.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Latest20Recovery20Trial20on20COVID-1920.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/dernier-essai-recovery-sur-la-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"Dernier essai RECOVERY sur la COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/30184","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=30184"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/30184\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/30203"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=30184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=30184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=30184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}